14 drug(s) with this reaction
42,480 total reports
Weight Decreased has been reported as an adverse reaction across 14 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 42,480 adverse event reports mention weight decreased in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with weight decreased, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have weight decreased listed in their FDA adverse event reports, sorted by report count:
In addition to weight decreased, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
14 drug(s) manufactured by Abbvie Inc have weight decreased listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, PANCRELIPASE, FENOFIBRATE, and others.
There are a combined 42,480 reports of weight decreased across 14 Abbvie Inc drug(s) in the FDA adverse event database.